Bio-gene Technology Ltd. · ASX:BGT
Bio-gene Technology — Shareholder Meeting (November 2021)
11 slides from Bio-gene Technology's shareholder meeting presentation, Nov 30, 2021
Slide 1: Bio-Gene Technology Limited Annual General Meeting
ENABLING THE NEXT GENERATION OF NOVEL INSECTICIDES BIO-GENE TECHNOLOGY LIMITED 30 NOVEMBER 2021 Annual General Meeting PRESENTED BY Robert Klupacs NON-EXECUTIVE CHAIRMAN Richard Jagger CEO & MANAGING DIRECTOR
Slide 2: Disclaimer
2021 ANNUAL GENERAL MEETING DISCLAIMER This presentation has been prepared by Bio-Gene Technology Limited (ASX:BGT) (the Company). This presentation is not, and should not be considered, an offer or invitation to apply for or purchase securities in the Company or as a recommendation or inducement to
Slide 3: Our Strategic Objective
2021 ANNUAL GENERAL MEETING OUR STRATEGIC Generate multiple revenue streams from technology licensing fees, milestone payments and royalties by OBJECTIVE Securing & owning active ingredient product registrations Working with strong commercial partners on product development; marketing and distributi
Slide 4: Important Positive Progress Over the Past 12 Months
2021 ANNUAL GENERAL MEETING IMPORTANT POSITIVE PROGRESS OVER THE PAST 12 MONTHS Additional MTAs signed with Board review and appointments global companies to undertake Confirmation of yield Clarke program stage 2 preliminary analysis of our improvements via extraction feedback & next steps Registrat
Slide 5: Consumer Products: Evergreen Commercial Development Agreement
2021 ANNUAL GENERAL MEETING CONSUMER PRODUCTS: EVERGREEN COMMERCIAL DEVELOPMENT AGREEMENT Evergreen is a market leader in consumer products across Europe and in Australia/New Zealand Market Opportunity Initial Field of Use Initial Territory Revenue Model Fly & mosquito electric evaporator E.U., U.K.
Slide 6: Public Health: New Option Agreement Signed on Clarke Mosquito Project
2021 ANNUAL GENERAL MEETING PUBLIC HEALTH: NEW OPTION AGREEMENT SIGNED ON CLARKE MOSQUITO PROJECT Clarke is the largest vertically integrated company in public health mosquito control Market Opportunity Initial Field of Use: Results of Phase 2 Testing New Option Agreement Signed Next Steps US$100m1
Slide 7: Crop Protection: Update on BASF Stored Grain Project
2021 ANNUAL GENERAL MEETING CROP PROTECTION: UPDATE ON BASF STORED GRAIN PROJECT BASF is the world’s largest chemical company Final stage of Phase 3 will show the ability for Flavocide, when used Details of Current Agreement Results of Phase 3 Testing Further Discussions in combination, to with BASF
Slide 8: Important Progress Across Other Key Areas
2021 ANNUAL GENERAL MEETING IMPORTANT PROGRESS ACROSS OTHER KEY AREAS I.P. Developments Additional MTAs Efficacy testing • Additional research underway has the potential • Bio-Gene has signed 4 new MTAs this • Additional studies underway for specific to identify new I.P. for the company calendar yea
Slide 9: Key Priorities for the Next 12 Months
2021 ANNUAL GENERAL MEETING KEY PRIORITIES FOR THE NEXT 12 MONTHS Optimising our Progressing manufacturing and development work production processes associated with existing partnerships Building our data to support efficacy, novel Mode of Action and regulatory approvals Broadening our future opport
Slide 10: A Clear Road Map for Generating Value
2021 ANNUAL GENERAL MEETING A CLEAR ROAD MAP FOR GENERATING VALUE 2024-2026 – MEDIUM TERM 2022-2024 2021-2022 • First regulatory approval and 2020-2021 • Additional commercial sales application testing - • Additional 2018-2020 • Manufacturing scale- internal and with registration up partners submiss
Slide 11: Thank You
ENABLING THE NEXT GENERATION OF NOVEL INSECTICIDES BIO-GENE TECHNOLOGY LIMITED 30 NOVEMBER 2021 Annual General Meeting THANK YOU
Bio-gene Technology — Shareholder Meeting (November 2021) on 6ix